Increased Uptake in Microcystic Serous Cystadenoma Mimicking Pancreatic Neuroendocrine Tumor on 68 Ga-DOTATATE PET/MRI.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
medline:
24
11
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
ppublish
Résumé
A 2.6-cm solid cystic lesion in the pancreatic head was found in a 51-year-old woman on CT. A pancreatic neuroendocrine tumor was suspected, and a 68 Ga-DOTATATE PET/MRI was performed, which showed increased tracer uptake in the lesion. However, postsurgical pathologic examination indicated a pancreatic serous cystadenoma. Here, we reported a case of microcystic pancreatic serous cystadenoma that could be misdiagnosed as a pancreatic neuroendocrine tumor on a 68 Ga-DOTATATE PET/MRI.
Identifiants
pubmed: 37756486
doi: 10.1097/RLU.0000000000004857
pii: 00003072-202311000-00022
doi:
Substances chimiques
copper dotatate CU-64
0
Gallium-68
98B30EPP5S
Organometallic Compounds
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
987-988Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: This research was supported by the National Natural Science Foundation of China (NSFC: 81971644) and the Shanghai Jiaotong University School of Medicine (KY20192098).
Références
European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut . 2018;67:789–804.
Ishigami K, Nishie A, Asayama Y, et al. Imaging pitfalls of pancreatic serous cystic neoplasm and its potential mimickers. World J Radiol . 2014;6:36–47.
Nougaret S, Mannelli L, Pierredon MA, et al. Cystic pancreatic lesions: from increased diagnosis rate to new dilemmas. Diagn Interv Imaging . 2016;97:1275–1285.
Chu LC, Singhi AD, Haroun RR, et al. The many faces of pancreatic serous cystadenoma: radiologic and pathologic correlation. Diagn Interv Imaging . 2017;98:191–202.
Nappo G, Funel N, Giudici S, et al. Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide positron emission tomography ( 68 Ga-DOTA-peptide PET-CT): a case report. BMC Surg . 2020;20:331.
Passand GT, Marichez A, Debordeaux F, et al. Serous cystadenoma mimicking cystic pancreatic neuroendocrine tumor on (68)Ga-DOTATOC PET/CT. Diagn Interv Imaging . 2022;103:563–565.
Bringeland EA, Rønne E, Kjellmo Å, et al. Pancreatic serous cystadenoma with a high 68 Ga DOTATOC-uptake mimicking a pancreatic NET. Int J Hepatobiliary Pancreat Dis . 2022;12:100097Z04EB2022.
Park HS, Kim SY, Hong SM, et al. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: differential diagnosis with neuroendocrine tumours. Eur Radiol . 2016;26:1348–1358.
Jang KM, Kim SH, Song KD, et al. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT. Clin Radiol . 2015;70:153–160.